Xuefei Shen

3.5k total citations · 1 hit paper
17 papers, 2.2k citations indexed

About

Xuefei Shen is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, Xuefei Shen has authored 17 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Epidemiology and 5 papers in Virology. Recurrent topics in Xuefei Shen's work include HIV Research and Treatment (5 papers), Microbial Inactivation Methods (4 papers) and Cervical Cancer and HPV Research (4 papers). Xuefei Shen is often cited by papers focused on HIV Research and Treatment (5 papers), Microbial Inactivation Methods (4 papers) and Cervical Cancer and HPV Research (4 papers). Xuefei Shen collaborates with scholars based in United States, China and Canada. Xuefei Shen's co-authors include Robert F. Siliciano, Karen Chadwick, Monika Hermankova, Harry L. Taylor, Tae‐Wook Chun, Patricia Barditch‐Crovo, Diana Finzi, Martha A. Zeiger, Ronald Brookmeyer and Lucy M. Carruth and has published in prestigious journals such as Nature, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Xuefei Shen

17 papers receiving 2.1k citations

Hit Papers

Quantification of latent tissue reservoirs and total body... 1997 2026 2006 2016 1997 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
    1997 1.6k citations Tae‐Wook Chun, Lucy M. Carruth et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefei Shen United States 12 1.6k 1.0k 916 442 349 17 2.2k
Catarina E. Hioe United States 27 1.1k 0.7× 479 0.5× 1.1k 1.2× 416 0.9× 532 1.5× 82 1.9k
Stephen D. Schmidt United States 25 1.8k 1.2× 734 0.7× 1.1k 1.2× 384 0.9× 542 1.6× 45 2.2k
Nafees Ahmad United States 22 1.2k 0.8× 915 0.9× 366 0.4× 360 0.8× 450 1.3× 55 1.8k
S P Cort United States 9 1.6k 1.0× 762 0.7× 1.1k 1.2× 441 1.0× 380 1.1× 12 2.1k
Jonathan M. Carlson United States 32 2.2k 1.4× 1.0k 1.0× 1.7k 1.9× 467 1.1× 812 2.3× 86 3.1k
Gary Landucci United States 24 2.2k 1.4× 655 0.6× 2.1k 2.2× 702 1.6× 764 2.2× 50 3.3k
Karin J. Metzner Switzerland 27 1.5k 0.9× 1.2k 1.2× 311 0.3× 365 0.8× 640 1.8× 102 2.3k
Anne‐Sophie Beignon France 23 618 0.4× 324 0.3× 1.5k 1.7× 377 0.9× 428 1.2× 43 2.1k
Gregory M. Laird United States 16 1.4k 0.9× 1.1k 1.1× 623 0.7× 418 0.9× 323 0.9× 29 1.8k
Miroslawa Bilska United States 15 1.9k 1.2× 810 0.8× 1.0k 1.1× 510 1.2× 465 1.3× 19 2.1k

Countries citing papers authored by Xuefei Shen

Since Specialization
Citations

This map shows the geographic impact of Xuefei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefei Shen more than expected).

Fields of papers citing papers by Xuefei Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefei Shen. The network helps show where Xuefei Shen may publish in the future.

Co-authorship network of co-authors of Xuefei Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefei Shen. A scholar is included among the top collaborators of Xuefei Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefei Shen. Xuefei Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Guan, Chen, et al.. (2024). Predicting the Pharmacological Targets of Astragalus membranaceus against Hypertensive Nephropathy. Letters in Drug Design & Discovery. 21(16). 3493–3505. 2 indexed citations
2.
Chen, Guan, Chenyu Li, Xuefei Shen, et al.. (2023). Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. European journal of medical research. 28(1). 344–344. 4 indexed citations
3.
Luan, Hong, Jianping Sun, Long Zhao, et al.. (2020). Resolvin D1 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Increasing Treg Percentages via the ALX/FPR2 Pathway. Frontiers in Physiology. 11. 285–285. 26 indexed citations
4.
Zhao, Long, et al.. (2020). Linarin Protects the Kidney against Ischemia/Reperfusion Injury <i>via</i> the Inhibition of Bioactive ETS2/IL-12. Biological and Pharmaceutical Bulletin. 44(1). 25–31. 11 indexed citations
5.
Lee, Hyojin, Moonsup Jeong, Youngran Cho, et al.. (2017). Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection. Scientific Reports. 7(1). 43531–43531. 18 indexed citations
6.
7.
Morrow, Matthew P., Kimberly A. Kraynyak, Xuefei Shen, et al.. (2014). Boosting of cellular and humoral immune responses to HPV16/18 antigens by VGX-3100: A follow-on phase I trial.. Journal of Clinical Oncology. 32(15_suppl). 3101–3101. 1 indexed citations
8.
9.
Bagarazzi, Mark L., Jian Yan, Matthew P. Morrow, et al.. (2012). Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses. Science Translational Medicine. 4(155). 155ra138–155ra138. 229 indexed citations
10.
Broderick, Kate E., Amy Chan, Feng Lin, et al.. (2012). Optimized In Vivo Transfer of Small Interfering RNA Targeting Dermal Tissue Using In Vivo Surface Electroporation. Molecular Therapy — Nucleic Acids. 1. e11–e11. 26 indexed citations
11.
Lin, Feng, Xuefei Shen, Gleb Kichaev, et al.. (2012). Optimization of Electroporation-Enhanced Intradermal Delivery of DNA Vaccine Using a Minimally Invasive Surface Device. Human Gene Therapy Methods. 23(3). 157–168. 44 indexed citations
12.
Shen, Xuefei, Jonas Söderholm, Feng Lin, et al.. (2012). Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model. Vaccine. 30(48). 6946–6954. 24 indexed citations
13.
Lin, Feng, Xuefei Shen, Janess Mendoza, et al.. (2011). A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine. 29(39). 6771–6780. 45 indexed citations
14.
Walker, L E, Lo Vang, Xuefei Shen, et al.. (2009). Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes. Vaccine. 27(50). 7087–7095. 7 indexed citations
15.
Wong, Soon Boon Justin, Christopher B. Buck, Xuefei Shen, & Robert F. Siliciano. (2004). An Evaluation of Enforced Rapid Proteasomal Degradation as a Means of Enhancing Vaccine-Induced CTL Responses. The Journal of Immunology. 173(5). 3073–3083. 26 indexed citations
16.
Shen, Xuefei, Soon Boon Justin Wong, Christopher B. Buck, Jiangwen Zhang, & Robert F. Siliciano. (2002). Direct Priming and Cross-Priming Contribute Differentially to the Induction of CD8+ CTL Following Exposure to Vaccinia Virus Via Different Routes. The Journal of Immunology. 169(8). 4222–4229. 68 indexed citations
17.
Chun, Tae‐Wook, Lucy M. Carruth, Diana Finzi, et al.. (1997). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387(6629). 183–188. 1611 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catarina E. Hioe Breakdown of academic impact, for papers by Stephen D. Schmidt Breakdown of academic impact, for papers by Nafees Ahmad Breakdown of academic impact, for papers by S P Cort Breakdown of academic impact, for papers by Jonathan M. Carlson Breakdown of academic impact, for papers by Gary Landucci Breakdown of academic impact, for papers by Karin J. Metzner Breakdown of academic impact, for papers by Anne‐Sophie Beignon Breakdown of academic impact, for papers by Gregory M. Laird Breakdown of academic impact, for papers by Miroslawa Bilska
Rankless by CCL
2026